QIAGEN press release
A peer-reviewed health-economic analysis evaluated TB infection (TBI) screening strategies among people living with HIV in Thailand. QuantiFERON-TB Gold Plus reduced the modeled lifetime risk of progression to active TB among individuals with TBI by approximately 41% compared with tuberculin skin test (TST).
The study was conducted to support evidence-based decision making in Thailand and to help policymakers in low- and middle-income countries evaluate screening options for detecting TB infection.
The analysis modeled one-time TBI screening in adults living with HIV and projected lifetime costs and health outcomes based on Thai epidemiological and cost data.
Read the full press release here.
For more TB updates, check out the TB CAB Weekly Newsletter (Issue #5, 15 February 2026).
The newsletter is brought to you by the Global TB Community Advisory Board (TB CAB) with the support of Treatment Action Group (TAG) and the European AIDS Treatment Group (EATG). Subscribe to the newsletter here.
Source : QIAGEN
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.